Literature DB >> 4041157

Argon laser photocoagulation in diabetic retinopathy: five year review of 697 treated eyes.

A S Lim, C Y Khoo, B C Ang, C Chiang.   

Abstract

Diabetic retinopathy has now become a common cause of blindness in Singapore. Fortunately, laser photocoagulation has prevented blindness in the majority of patients who were treated. An analysis of 872 patients treated with argon laser photocoagulation showed that 424 patients (48.6%) were for diabetic retinopathy. Patients with adequate treatment retained useful vision. Those who lost vision frequently had associated target organ involvement besides inadequate laser treatment. Patients with proliferative diabetic retinopathy were treated with peripheral retinal photocoagulation. Patients with diabetic maculopathy especially those with focal leaks were treated with localised photocoagulation. A common cause of blindness is failure to recognise the condition early. Physicians and general practitioners must, in the management of diabetics, examine their patients periodically with the pupils dilated in a darkened room.

Entities:  

Mesh:

Year:  1985        PMID: 4041157

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  1 in total

1.  Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.

Authors:  Homayoun Nikkhah; Hossein Ghazi; Mohammad Reza Razzaghi; Saeed Karimi; Alireza Ramezani; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2017-02-06       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.